Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: A retrospective study

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Manno, Rebecca L ^a   Seo, Philip ^a   Geetha, Duvuru ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANCA; Elderly; Hemodialysis; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RITUXIMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; AGE; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOTHERAPY; ONSET AGE; PLASMAPHERESIS; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; COMPLICATION; DISEASE COURSE; GRANULOMATOSIS WITH POLYANGIITIS; KIDNEY FAILURE, CHRONIC; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; GRANULOMATOSIS WITH POLYANGIITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MYCOPHENOLIC ACID; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RITUXIMAB; YOUNG ADULT;

EID: 84934269979     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0082-9     Document Type: Article

References (19)

1. CDC. The State of Aging and Health in America. 2013. http://www.cdc.gov/aging/pdf/state-aging-health-in-america-2013.pdf, accessed on 5/8/15
2. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43(2):414-9.
3. Langford CA. Vasculitis in the geriatric population. Clin Geriatr Med. 2005;21(3):631-647, viii.
4. Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013;12(4):477-82.
5. Day CJ, Howie AJ, Nightingale P, et al. Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis. 2010;55(2):250-8.
6. Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488-94.
7. de Joode AA, Sanders JS, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8(10):1709-17.
8. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41(4):776-84.
9. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology (Oxford). 2001;40(5):492-8.
10. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology (Oxford). 2005;44(4):495-501.
11. Lee T, Gasim A, Derebail VK, et al. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014;9(5):905-13.
12. De Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2007;18(7):2189-97.
13. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628-36.
14. Tanna A, Guarino L, Tam FW, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant. 2014; [Epub ahead of print].
15. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of the Vasculitides. Arthritis Rheum. 2013;65(1):1-11.
16. Bomback AS, Appel GB, Radhakrishnan J, et al. ANCA-associated glomerulonephritis in the very elderly. Kidney Int. 2011;79(7):757-64.
17. Li ZY, Gou SJ, Chen M, Zhao MH. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum. 2013;42(5):515-21.
18. Szpirt WM. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis - a 25-year perspective. Nephrol Dial Translplant. 2015;30 Suppl 1:i146-9.
19. Bomback AS, Appel GB. ANCA-associated GN - to PLEX or not to PLEX? Nat Rev Nephrol. 2013;9:436-8.